[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Survey and Trend Research 2018

June 2018 | 117 pages | ID: GD113A8B984EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Achelios Therapeutics Inc, Advinus Therapeutics Ltd, Apollo Endosurgery Inc, Aptinyx Inc, Can-Fite BioPharma Ltd, Can-Fite BioPharma Ltd, Celgene Corp, DermaXon LLC, Eisai, Immune Pharmaceuticals Inc, INSYS Therapeutics Inc, Kineta Inc, KPI Therapeutics Inc, Krenitsky Pharmaceuticals Inc, MAKScientific LLC, Metys Pharmaceuticals AG, Midatech Pharma US Inc, Mundipharma International Ltd, Nemus Bioscience Inc, Neurocentrx Pharma Ltd, Panacea Pharmaceuticals Inc, PeriphaGen Inc, PharmatrophiX Inc, PledPharma AB, Sova Pharmaceuticals Inc, Virobay Inc, WEX Pharmaceuticals Inc etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Chemotherapy Induced Peripheral Neuropathy Treatment Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 Key Companies List
4.1 Achelios Therapeutics Inc (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Advinus Therapeutics Ltd (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Apollo Endosurgery Inc (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Aptinyx Inc (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Can-Fite BioPharma Ltd (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Can-Fite BioPharma Ltd (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Celgene Corp (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 DermaXon LLC (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Eisai (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Immune Pharmaceuticals Inc (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 INSYS Therapeutics Inc (Company Overview, Sales Data etc.)
4.12 Kineta Inc (Company Overview, Sales Data etc.)
4.13 KPI Therapeutics Inc (Company Overview, Sales Data etc.)
4.14 Krenitsky Pharmaceuticals Inc (Company Overview, Sales Data etc.)
4.15 MAKScientific LLC (Company Overview, Sales Data etc.)
4.16 Metys Pharmaceuticals AG (Company Overview, Sales Data etc.)
4.17 Midatech Pharma US Inc (Company Overview, Sales Data etc.)
4.18 Mundipharma International Ltd (Company Overview, Sales Data etc.)
4.19 Nemus Bioscience Inc (Company Overview, Sales Data etc.)
4.20 Neurocentrx Pharma Ltd (Company Overview, Sales Data etc.)
4.21 Panacea Pharmaceuticals Inc (Company Overview, Sales Data etc.)
4.22 PeriphaGen Inc (Company Overview, Sales Data etc.)
4.23 PharmatrophiX Inc (Company Overview, Sales Data etc.)
4.24 PledPharma AB (Company Overview, Sales Data etc.)
4.25 Sova Pharmaceuticals Inc (Company Overview, Sales Data etc.)
4.26 Virobay Inc (Company Overview, Sales Data etc.)
4.27 WEX Pharmaceuticals Inc (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2012-2017, by Type, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2012-2017, by Type, in Volume
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast 2018-2023, by Type, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast 2018-2023, by Type, in Volume
Table Achelios Therapeutics Inc Overview List
Table 0 Business Operation of Achelios Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Advinus Therapeutics Ltd Overview List
Table 0 Business Operation of Advinus Therapeutics Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apollo Endosurgery Inc Overview List
Table 0 Business Operation of Apollo Endosurgery Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aptinyx Inc Overview List
Table 0 Business Operation of Aptinyx Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Can-Fite BioPharma Ltd Overview List
Table 0 Business Operation of Can-Fite BioPharma Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Can-Fite BioPharma Ltd Overview List
Table 0 Business Operation of Can-Fite BioPharma Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corp Overview List
Table 0 Business Operation of Celgene Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DermaXon LLC Overview List
Table 0 Business Operation of DermaXon LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Overview List
Table 0 Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Immune Pharmaceuticals Inc Overview List
Table 0 Business Operation of Immune Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table INSYS Therapeutics Inc Overview List
Table 0 Business Operation of INSYS Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kineta Inc Overview List
Table 0 Business Operation of Kineta Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table KPI Therapeutics Inc Overview List
Table 0 Business Operation of KPI Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Krenitsky Pharmaceuticals Inc Overview List
Table 0 Business Operation of Krenitsky Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MAKScientific LLC Overview List
Table 0 Business Operation of MAKScientific LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Metys Pharmaceuticals AG Overview List
Table 0 Business Operation of Metys Pharmaceuticals AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Midatech Pharma US Inc Overview List
Table 0 Business Operation of Midatech Pharma US Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mundipharma International Ltd Overview List
Table 0 Business Operation of Mundipharma International Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nemus Bioscience Inc Overview List
Table 0 Business Operation of Nemus Bioscience Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Neurocentrx Pharma Ltd Overview List
Table 0 Business Operation of Neurocentrx Pharma Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Panacea Pharmaceuticals Inc Overview List
Table 0 Business Operation of Panacea Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PeriphaGen Inc Overview List
Table 0 Business Operation of PeriphaGen Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PharmatrophiX Inc Overview List
Table 0 Business Operation of PharmatrophiX Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PledPharma AB Overview List
Table 0 Business Operation of PledPharma AB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sova Pharmaceuticals Inc Overview List
Table 0 Business Operation of Sova Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Virobay Inc Overview List
Table 0 Business Operation of Virobay Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table WEX Pharmaceuticals Inc Overview List
Table 0 Business Operation of WEX Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue Share, by Companies, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Volume 2012-2017, by Companies, in Volume
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue Share, by Companies in 2017, in Volume
Table Chemotherapy Induced Peripheral Neuropathy Treatment Demand 2012-2017, by Application, in USD Million
Table Chemotherapy Induced Peripheral Neuropathy Treatment Demand 2012-2017, by Application, in Volume
Table Chemotherapy Induced Peripheral Neuropathy Treatment Demand Forecast 2018-2023, by Application, in USD Million
Table Chemotherapy Induced Peripheral Neuropathy Treatment Demand Forecast 2018-2023, by Application, in Volume
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2012-2017, by Region, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2012-2017, by Region, in Volume
Table Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast 2018-2023, by Region, in USD Million
Table Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Chemotherapy Induced Peripheral Neuropathy Treatment Industry Chain Structure
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth 2012-2017, by Type, in USD Million
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth 2012-2017, by Type, in Volume
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications